What does this research mean for the field?

Prolonged use of the Impella 5.5 support is a safe bridging strategy for heart transplantation, resulting in comparable post-transplant outcomes regardless of support duration. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study aims to evaluate the effect of prolonged Impella 5.5 support on outcomes after heart transplantation.

February 27, 20260 citations

Impact of Prolonged Impella 5.5 Support on Post-Transplant Outcomes: An Institutional Study.

View Full Paper

DRDavid RekhtmanHospital of the University of Pennsylvania AIAmit Iyengar CSCindy SongHospital of the University of Pennsylvania

Key Points

The study aims to evaluate the effect of prolonged Impella 5.5 support on outcomes after heart transplantation.
Analyzed outcomes of patients receiving heart transplants with prolonged Impella 5.5 support.
Stratified patients based on the duration of support before transplantation.
Assessed post-transplant outcomes including survival and functional status.
Patients with prolonged Impella 5.5 support showed comparable post-transplant outcomes to those with shorter durations.
No significant increase in complications was observed in the prolonged support group.
The findings support the safety of using prolonged microaxial flow pumps as a bridging strategy.

Abstract

Use of a prolonged microaxial flow pump may be a safe bridging strategy for heart transplantation given comparable post-transplant outcomes for patients stratified by support duration.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Rekhtman et al. (Sun,) studied this question.

synapsesocial.com/papers/69a13591ed1d949a99abf83b https://doi.org/https://doi.org/10.1111/ctr.70452

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Demander à l'IA

Bookmark

View Full Paper